People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $60.0M | $765.1M | 2010 |
| Rhythm Holding Company, LLC | — | Pharmaceuticals | Series A | $11.0M | $340.7M | 2013 |
Christian De La Tour at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christian De La Tour on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edward Mathers | 2 | 12 |
| Keith Gottesdiener | 2 | 4 |
| Bart Henderson | 2 | 3 |
| Lou Tartaglia | 2 | 3 |
| Todd Foley | 1 | 12 |
| Steven St. Peter | 1 | 4 |
| Vaughn M. Kailian | 1 | 3 |
| Vaughan Kailian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.